Sanofi-Aventis Closes In On Diabetics In India; Big Push On Rural Markets And New Launches
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - With the number of diabetics in India swelling to over 50 million this year according to multiple estimates, large brand companies are developing novel strategies and expanded services to bond with diabetes patients
You may also be interested in...
Sanofi-Aventis APAC Business Development VP Arjun Oberoi On Innovation Pacts And Deal-Making In Asia: An Interview With PharmAsia News (Part 1 of 2)
Arjun Oberoi, Sanofi-Aventis' vice president for business development Asia Pacific, mirrors his company's leadership ambitions in the Asian markets. Open to calculated risks and high on energy, Oberoi has played a leading role in clinching a few important deals for Sanofi such as last year's acquisition of China OTC play BMP Sunstone and its joint venture with Minsheng Pharmaceutical Group ('Sanofi Expands Consumer Health Reach With New Joint Venture In China,' PharmAsia News, Feb. 1, 2010).
Sanofi-Aventis APAC Business Development VP Arjun Oberoi On Innovation Pacts And Deal-Making In Asia: An Interview With PharmAsia News (Part 1 of 2)
Arjun Oberoi, Sanofi-Aventis' vice president for business development Asia Pacific, mirrors his company's leadership ambitions in the Asian markets. Open to calculated risks and high on energy, Oberoi has played a leading role in clinching a few important deals for Sanofi such as last year's acquisition of China OTC play BMP Sunstone and its joint venture with Minsheng Pharmaceutical Group ('Sanofi Expands Consumer Health Reach With New Joint Venture In China,' PharmAsia News, Feb. 1, 2010).
Only Private Industry Can Reach India's Rural Population As Government Focuses On Disease Prevention
HONG KONG - Trying to improve the quality of its healthcare services, India plans to reach out to its vast rural population while looking to create partnership opportunities within the private sector